E. R. KOÇ Et Al. , "Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study," 8th Congress of the European Academy of Neurology , VİYANA, Austria, 2022
KOÇ, E. R. Et Al. 2022. Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study. 8th Congress of the European Academy of Neurology , (VİYANA, Austria).
KOÇ, E. R., SARIDAŞ, F., CEYLAN, D., TURAN, Ö. F., & ÖZKAYA, G., (2022). Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study . 8th Congress of the European Academy of Neurology, VİYANA, Austria
KOÇ, EMİNE Et Al. "Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study," 8th Congress of the European Academy of Neurology, VİYANA, Austria, 2022
KOÇ, EMİNE R. Et Al. "Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study." 8th Congress of the European Academy of Neurology , VİYANA, Austria, 2022
KOÇ, E. R. Et Al. (2022) . "Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study." 8th Congress of the European Academy of Neurology , VİYANA, Austria.
@conferencepaper{conferencepaper, author={EMİNE RABİA KOÇ Et Al. }, title={Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study}, congress name={8th Congress of the European Academy of Neurology}, city={VİYANA}, country={Austria}, year={2022}}